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Background: Gracilaria changii (Xia et Abbott) Abbott, Zhang et Xia, a red algae commonly found in the coastal
areas of Malaysia is traditionally used for foods and for the treatment of various ailments including inflammation
and gastric ailments. The aim of the study was to investigate anti-inflammatory, gastroprotective and anti-
ulcerogenic activities of a mass spectrometry standardized methanolic extract of Gracilaria changii.
Methods: Methanolic extract of Gracilaria changii (MeOHGCM6 extract) was prepared and standardized using mass
spectrometry (MS). Anti-inflammatory activities of MeOHGCM6 extract were examined by treating U937 cells during
its differentiation with 10 μg/ml MeOHGCM6 extract. Tumour necrosis factors-α (TNF-α) response level and TNF-α
and interleukin-6 (IL-6) gene expression were monitored and compared to that treated by 10 nM betamethasone,
an anti-inflammatory drug. Gastroprotective and anti-ulcerogenic activities of MeOHGCM6 extract were examined
by feeding rats with MeOHGCM6 extract ranging from 2.5 to 500 mg/kg body weight (b.w.) following induction of
gastric lesions. Production of mucus and gastric juice, pH of the gastric juice and non-protein sulfhydryls (NP-SH)
levels were determined and compared to that fed by 20 mg/kg b.w. omeprazole (OMP), a known anti-ulcer drug.
Results: MS/MS analysis of the MeOHGCM6 extracts revealed the presence of methyl 10-hydroxyphaeophorbide a
and 10-hydroxypheophytin a, known chlorophyll proteins and several unidentified molecules. Treatment with
10 μg/ml MeOHGCM6 extract during differentiation of U937 cells significantly inhibited TNF-α response level and
TNF-α and IL-6 gene expression. The inhibitory effect was comparable to that of betamethasone. No cytotoxic
effects were recorded for cells treated with the 10 μg/ml MeOHGCM6 extract. Rats fed with MeOHGCM6 extract at
500 mg/kg b.w. showed reduced absolute ethanol-induced gastric lesion sizes by > 99% (p < 0.05). This protective
effect was comparable to that conferred by OMP. The pH of the gastric mucus decreased in dose-dependent
manner from 5.51 to 3.82 and there was a significant increase in NP-SH concentrations.
Conclusions: Results from the study, suggest that the mass spectrometry standardized methanolic extract of
Gracillaria changii possesses anti-inflammatory, gastroprotective and anti-ulcerogenic properties. Further
examination of the active constituent of the extract and its mechanism of action is warranted in the future.
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Inflammation is a major feature of many diseases. It is
characterized by a complex of orchestrated interactions
between mediators of inflammation and inflammatory cells
directed toward removing irritants and healing of tissue
injuries [1,2]. Inflammation is an important host defence
mechanism. Inflammation that occurs in the mucosal of
gastrointestinal tract, however, causes gastrointestinal
ulcer [3]. Gastrointestinal ulcer is a common major
disorder of the digestive system affecting millions of
Americans and many more worldwide [4]. The most
common cause of gastrointestinal ulcer disease are
infection with Helicobacter pylori (H. pylori) [5] and
long-term use of nonsteroidal anti-inflammatory drugs
(NSAIDs) such as aspirin and ibuprofen [6]. The advent
of antibiotic controls against H. pylori has significantly
reduced the number of gastrointestinal ulcer cases in
the developed countries [7]. The disease however, is still
high in other countries and the disease caused by the
use of NSAIDs is still a major health concern in the
developed countries [6,7].
Treatment for inflammation in general, is aimed at
either inhibiting the activity of inflammatory cells or
inhibiting the production of inflammatory mediators
[8]. The later can be accomplished using drugs such as
NSAIDs and corticosteroids [9]. Treatment for gastro-
intestinal ulcer in general, is aimed at either eliminating
H. pylori infection or reducing and inhibiting the levels
of gastric acid production responsible for the erosion of
gastrointestinal protective layer [10,11]. The later can
be accomplished using drugs such as histamine (H2)-
blockers, acid pump inhibitors and mucosal protective
medications [9]. However, various side effects of long
term use of these drugs have been described [9]. In
addition, anti-inflammation and anti-ulcerogenic drugs
are used mainly to alleviate the symptoms of the disease
without actually treating or preventing the inflamma-
tory and ulcerogenic processes.
Development of anti-inflammatory and anti-ulcerogenic
drugs has recently focused on discovering the favourable
application of herbal plant-derived extracts that are potent
and safer to use. Algae found growing in abundance off
the coastal areas of many parts of the world represent a
huge yet untapped potential for new source of therapeu-
tics [12,13]. The red algae for example has been
reported to contain active compounds that may help
ameliorate inflammation of the alimentary tract [14],
prevent or treat gastric ulcers and cancers caused by
oxidative stress [15,16], inhibit inflammatory activities
by suppressing the production of inflammatory media-
tors [17-19] and induce cancer cell apoptosis in stomach
[20] and colon [21]. Natural compounds derived from
the edible algae could be safer to be used as anti-
inflammatory and gastric anti-ulcerogenic therapeuticsas they have been taken as food and used in traditional
medicines since time immemorial [13].
The red algae, Gracilaria changii (Xia et Abbott)
Abbott, Zhang et Xia found growing off the coastal
areas of Malaysia represents a potential local source of
this naturally-derived therapeutics. Presently, the algae
are commercially harvested only for its colloidal agar
content and as local food delicacies. These algae are
widely applied as folk medicine for the treatment of
various ailments including inflammation and gastric ail-
ments. The present study aims to evaluate the potential
anti-inflammatory, gastroprotective and anti-ulcerogenic
activities of these Malaysian red algae, Gracilaria changii.Methods
Algae extract preparation
Gracilaria changii (Xia et Abbott) Abbott, Zhang et Xia
were collected from the coastal water of Morib, Selangor,
Malaysia (N2° 44′ 908″, E101° 26′ 590″) in late February
2003 [22-24]. The algae were identified by Professor Dr.
Phang Siew Moi, Director of the Institute of Ocean and
Earth Sciences, Institute of Biological Sciences, Faculty of
Science, University of Malaya, where the voucher speci-
mens were maintained (herbarium no. PSM 6320 and
PSM 6321). The algae were washed in sterile seawater
with a final rinse in sterile distilled water as previously
described [22]. The algae were then sonicated in a water
bath sonicator and kept at −70°C. Methanolic extract of
Gracilaria changii (MeOHGCM6 extract) was prepared at
the University of Malaysia Terengganu (UMT) in accord-
ance to the methods described [25]. The MeOHGCM6
extract was kept at −20°C prior to use.MeOHGCM6 extract
Profile analysis of the MeOHGCM6 extract was performed
on a Shimadzu ultra-fast liquid chromatography (UFLC)
system equipped with photodiode array ultraviolet
(PDA UV) detector and ion trap time of flight (TOF)
mass spectrometer (Shimadzu, Japan). The separation
was achieved on a Waters Xbridge C18 column (50 mm
× 2.1 mm, particle diameter of 2.5 μm) (Water, USA) at
40°C. The mobile phase consisted of water [0.1% formic
acid (BDH Laboratory Supplies, England)] : acetonitrile
(BDH Laboratory Supplies, England) (0.1% formic acid)
at a flow rate of 0.50 ml/min with an injection volume
of 10 μl. Electrospray ionization (ESI) mode with positive/
negative switching and external reference was used for
mass spectrometry (MS). The Dictionary of Natural
Products (CRC Press) with high resolution MS spectra
and structural information was used to analyse the positive
and negative ion spectra along with MS/MS information
for identification of similar components.
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U937 cells were purchased from American Type Cul-
ture Collection (ATTC, USA) and cultured in Roswell
Park Memorial Institute-1640 (RPMI-1640 medium)
(Flowlab, Australia) [supplemented with 1% of 10 mM
non-essential amino acid (NEAA) (Flowlab, Australia)
and 1% of 10 mM L-glutamine (L-Glu) (Flowlab,
Australia)] containing 10% heat-inactivated fetal bovine
serum (FBS) (Flowlab, Australia). Cells were incubated
at 37°C in a humidified incubator with 5% CO2.
Differentiation of U937 cells
U937 cells were seeded in 96-well cell culture plates
(Falcon, USA) at a density of 2 × 104 cells/well with
RPMI-1640 medium containing 2% FBS and kept at 37°C
in a humidified incubator with 5% CO2. The following
day, medium containing phorbol 12-myristate 13-acetate
(PMA) (Sigma-Aldrich, USA) at concentrations ranging
from 0–50 nM were added to the U937 monocytic cells
to induce differentiation for 24 and 48 hours. Medium
containing only PMA diluents [dimethyl sulfoxide
(DMSO) solution (Sigma-Aldrich, USA)] were added
in parallel and used as vehicle control. At the end of
the indicated time point, cells were evaluated for
differentiation-specific macrophage cell surface marker
expression and cell viability.
Expression of the CD11b, differentiation-specific macro-
phage cell surface marker was determined by staining cells
as previously described [26,27]. Cell viability was deter-
mined using the trypan blue dye (Sigma, USA) exclusion
assay as previously described [28].
Cytotoxicity assay
U937 cells were seeded in 96-well cell culture plates at a
density of 2 × 104 cells/well with RPMI-1640 medium
containing 2% FBS and kept at 37°C in a humidified
incubator with 5% CO2. The following day, medium
containing MeOHGCM6 extract (at concentrations ran-
ging from 0–100 μg/ml) and betamethasone (Sigma,
USA) (at concentrations ranging from 0–100 nM) were
added. Medium containing only the MeOHGCM6 extract
and betamethasone diluents [ethanol (EtOH) (BDH
Laboratory Supplies, England) and DMSO, respectively]
were added in parallel and used as vehicle control. A day
post-treatment, the U937 cells proliferation rate was
determined using the CellTiter 96W Non-Radioactive Cell
Proliferation kit (Promega, USA) strictly following the
manufacturer’s recommended protocol.
MeOHGCM6 extract treatment of U937 cells
U937 cells were seeded in 24-well cell culture plates
(Falcon, USA) at a density of 2 × 105 cells/well with
RPMI-1640 medium containing 2% FBS and incubated
at 37°C in a humidified incubator with 5% CO2. Thefollowing day, the U937 cells were induced to differentiate
with 10 nM PMA for 24 hours. During differentiation, the
U937 cells were treated with the MeOHGCM6 extract or
betamethasone at physiologic concentration. At 0, 8, 16
and 24 hours post-treatment, supernatant and cells were
harvested and assayed for TNF-α response level and
TNF-α and IL-6 gene expression.
TNF-α response level
TNF-α level was measured using the BD OptEIA™
Human TNF (TNF-α) ELISA kit II (BD Biosciences,
USA) according to the manufacturer’s protocol.
TNF-α and IL-6 gene expression
Total RNA from the cell cultures were isolated using the
TRI ReagentW (Molecular Research Centre, Inc., USA)
and treated with DNase (Promega, USA). RNA was
reverse-transcribed (cDNA) using the SuperScript™ II
Reverse Transcriptase (Invitrogen, USA). The cDNA was
then used to perform quantitative real-time PCR using
SYBRW Green PCR master mix (Qiagen, Germany) on
DNA Engine Opticon IIW (MJ Research, Bio-Rad, USA) as
previously described [29]. The oligonucleotide primers used
were forward 5′AAGAGTTCCCCAGGGACCTC and
reverse 5′GCTTGAGGGTTTGCTACAAC for TNF-α;
forward 5′GAAAGGAGACATGTAACAAG and reverse
5′CCAGGCAAGTCTCCTCATTG for IL-6; and forward
5′GCGAGAAGATGACCCAGATC and reverse 5′
GGATAGCACAGCCTGGATAG for beta-actin
(β-actin) (internal reference).
Animals
Adult female Sprague–Dawley rats aged between 7 to 8
weeks and weighing 160–200 g were used for the study.
The protocol for animal experiments was approved by the
Institutional Committee for Ethics in Animal Experimen-
tation of the University of Malaya [Approval Number:
MP/08/06/2010/SMH(R)]. The animals were obtained
from University Putra Malaysia (UPM). The animals were
housed individually in cages with wide-mesh wire bottoms
to prevent coprophagy. They were kept in a temperature-
controlled room that was well ventilated, with food and
water, on a 12 hour light/dark cycle throughout the study.
All rats were deprived of food for 48 hours, but had free
access to drinking water until 2 hours prior to subjecting
them to the ulcerogens.
EtOH-induced gastric lesions
The rats were randomly divided into 7 groups with each
group comprising of 6 rats. Group 1 was administered
with 10% Tween 20 (extract diluents) (BDH Laboratory
Supplies, England) and served as negative control group.
Group 2 was given 500 mg/kg b.w. of the MeOHGCM6
extract-equivalent unrelated plant extract similarly prepared
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specific plant extract (NSPE) control group. Group 3 was
treated with OMP (Chemical Company of Malaysia,
Malaysia) at 20 mg/kg b.w. and served as the positive
treatment control group. The remaining group 4, 5, 6 and
7 received 4 different concentrations of the MeOHGCM6
extract ranging from 2.5 - 500 mg/kg b.w., respectively.
After 30 minutes of pre-treatment, all animals were
administered with absolute EtOH through the oral route.
One hour post-administration, the animals were sacrificed
by over-dosing them with diethyl ether (BDH Chemicals
Ltd., England). The rat’s abdomen was dissected and the
oesophagus nearest to the cardia and the distended stom-
ach on the pyloric sphincter was immediately tied in a
knot using a string to avoid leakage of the gastric contents.
The stomach was rapidly removed and immersed in
water.
Measurement of gastric secretion
The gastric content of each rat stomach was aspirated
and gently scraped using a spatula. The stomach juice
containing food particles was discarded. The harvested
gastric mucus was weighed using electronic balance
(Mettler Toledo, Switzerland). The amount of gastric-
juice was measured using a measuring cylinder. The pH
of the gastric content was measured using a digital pH
meter (Crison Instruments, S.A., Spain).
Evaluation of gross gastric lesions
Following the harvest, the stomach was immediately
flushed with saline and examined under a dissecting
microscope (1.8 ×) with a square grid eyepiece. The
glandular portion of the stomach was assessed for the
formation of ulcer. The total ulcerating area (UA) of the
haemorrhagic lesions for each stomach was measured by
plannimetry (mm2) and the percentage of inhibition was
calculated using the following formula:
Inhibition %ð Þ ¼ UA control–UA treatedð Þ=UA control½ 
 100
Determination of production of non-protein sulfhydryls
(NP-SH)
Gastric mucosal NP-SH level was measured as previously
described [30] with minor modification. Briefly, the glandu-
lar stomach was weighed and homogenized in tubes
containing ice-cold 0.02 M ethylenediaminetetraacetic acid
(EDTA) (GibcoBRL Life Technologies, USA) (pH 8.9).
Aliquots of the homogenates were mixed with distilled
water and 50% trichloroacetic acid (Sigma Chemical
Co., USA). The mixture was incubated with constant
agitation for 10 minutes at 4°C and then centrifuged at
3000 × g for 15 minutes. The mixture was then assayedfor NP-SH level using a glutathione assay kit (Sigma
Chemical Co., USA) according to the manufacturer’s
protocol.
Statistical analysis
All data were expressed as mean ± standard deviation
(S.D.) or median (25% and 75% quartile) from two or three
independent experiments for anti-inflammatory studies and
seven independent experiments for gastroprotective and
anti-ulcerogenic studies. ANOVA (one-way analysis of
variance and two-way analysis of variance) was used for
the comparison among groups and for reporting the
statistical significance ‘p’ with respect to the control
group. The value of p < 0.05 was considered statistically
significant. All statistical analyses were done using the
GraphPad Prism 4.0 Software (USA) and SPSS version
16.0 Software (SPSS Inc, Chicago), respectively.
Results
Standardised MeOHGCM6 extract profile
LC/MS analyses of the different batches of MeOHGCM6
extract were performed to ensure reproducibility and
consistency of the extraction methods. Batch 1 and 2 of
MeOHGCM6 extract used in the study showed highly
similar mass spectral profiles and quantity of the major
masses (Figure 1A-C). Analysis of the spectra and com-
parison to the Dictionary of Natural Products, CRC Press
identified the distinctive masses as 457.405, 645.280 and
887.579. The identified mass in the positive ion spectrum
of m/z 457.405, had fragments of 398.327 (base peak),
380.316 and 158.082. The neutral loss of 59.077 mass was
possibly indicative of lost of trimethylamine. This suggests
that the compound may contain a trimethylammonium
moiety. The high resolution MS and MS/MS data could
not definitively identify any known compounds from the
Dictionary of Natural Products. The masses of m/z 645
and 887, however, showed a distinct association to two
known chlorophylls, methyl 10-hydroxyphaeophorbide a
and 10-Hydroxypheophytin a with the appropriate UV
absorbances observed in the PDA analysis (Table 1).
Differentiation-specific macrophage cell surface marker
expression on U937 cells
Differentiated U937 cells are distinguished by the ex-
pression of the monocyte/macrophages lineage-specific
CD11b, surface marker protein [26]. In our study, the
expression of the CD11b was marked with an intense
brownish blue labelling on the cell surface [27]. The
expression of the CD11b was greatly increased when the
U937 cells were induced to differentiate with increasing
concentration of PMA (1, 10 and 50 nM) (Figure 2,
Figure 3A). The finding suggested that treatment with
10 or 50 nM PMA for 24 hour or 1 nM PMA for
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Figure 1 Profiling of the different batches of MeOHGCM6 extract. ESI mode with positive/negative switching and external reference was
used for the MS using a Shimadzu UFLC system. Total positive ion spectra analysed for identification of similar components from the two
different batches of the MeOHGCM6 extract used in the study. (A) MeOHGCM6 extract (Batch 1; M6-1). (B) MeOHGCM6 extract (Batch 2; M6-2).
(C) Comparison of the intensity of the most abundant masses of the two MeOHGCM6 extract batches used in the study.
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the cell culture.
Cell viability determination on differentiated U937 cells
The viable differentiated U937 cells were scored using
the trypan blue dye exclusion assay. U937 cells viabilityexhibited a significant dose-dependent reduction in the
percentage of viable cells when induced to differentiate
with 1, 10 and 50 nM PMA (Figure 3B). The finding
suggested that 90% of the differentiated U937 cells were
still viable following treatment with 1 or 10 nM PMA
for 24 hour or 1 nM PMA for 48 hour.
Table 1 Structure identifications of the most significant
mass present in MeOHGCM6 extract using LC/MS
Mass (ion) Found in batch Possible ID
417.298 1, 2 Most likely contaminant
457.405* 1, 2 Unidentified
461.326 1, 2 Most likely contaminant
505.353 1, 2 Most likely contaminant
573.256 1, 2 Unidentified
645.280 1, 2 Methyl 10-hydroxyphaeophorbide a
743.636 1, 2 Unidentified
887.579 1, 2 10-Hydroxypheophytin a
Dictionary of Natural Products, CRC Press with high resolution MS spectra
were used to analyse the total positive ion spectra for the identification of
possible chemical constituents.
* MS/MS (relative intensities%) 457.405→ 398.327 (100%), 380.316 (50%),
158.082 (40%).
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The cytotoxic effects of the MeOHGCM6 extract and
betamethasone on the U937 cells were determined by
calculating the cell proliferation rate. Treated U937 cells
with the MeOHGCM6 extract at 0.05, 0.5, 1 and 5 μg/ml
exhibited proliferative bursts of 117.39% (108.48%,
122.10%), 152.04% (149.36%, 154.72%) (p < 0.05), 145.60%
(137.48%, 149.11%) (p < 0.05) and 118.49% (112.01%,
133.28%), respectively (Figure 4A). Treatment with
MeOHGCM6 extract at 10 μg/ml reduced the cell prolif-
eration rate to 87.00% (82.43%, 89.62%). Treated U937
cells with the betamethasone exhibited significant dose-
dependent reduction in their proliferation rate (Figure 4B).
At lower concentrations of betamethasone (0.1, 1, 5 and
10 nM), the cell proliferation rate was 110.35% (92.20%,
115.83%), 113.75% (89.56%, 122.98%), 94.59% (85.56%,
101.93%) and 80.48% (77.78%, 110.48%), respectively.
Effects of MeOHGCM6 extract treatment on the TNF-α
response level during differentiation of the U937 cells
The effects of MeOHGCM6 extract treatment on the
regulation of TNF-α response level during the U937
cells differentiation was investigated using ELISA. The
TNF-α response level reached a maximum level of
43.28 ± 5.15 pg/ml at 8 hours when the U937 cells were
induced to differentiate (Figure 5A). In the presence of
10 μg/ml MeOHGCM6 extract during differentiation of
U937 cells, the TNF-α response level significantly decreased
till 8 hours [0.14 ± 0.28 pg/ml (p < 0.001)] and was compar-
able to that observed in the presence of betamethasone
[0.28 ± 0.56 pg/ml (p < 0.001)].
Effects of MeOHGCM6 extract treatment on the TNF-α
and IL-6 gene expression during differentiation of the
U937 cells
The regulation of TNF-α and IL-6 by MeOHGCM6
extract treatment during the U937 cells differentiationwas further investigated at the gene expression level
using qRT-PCR. The TNF-α gene expression level
peaked after 6 hours (3.16 ± 0.48 copies/actin) of the
U937 cells differentiation (Figure 5B). TNF-α gene expres-
sion level decreased during the first 6 hours [0.52 ± 0.28
copies/actin (p < 0.001)] of U937 cells differentiation in
the presence of 10 μg/ml MeOHGCM6 extract. The
decreased in the TNF-α gene expression level of U937
cells during differentiation when treated with 10 μg/ml
MeOHGCM6 was comparable to or better than the
findings from the treatment with 10 nM betamethasone
[0.55 ± 0.42 copies/actin (p < 0.001)]. The IL-6 gene ex-
pression level showed a significant increase and peaked
at 0.68 ± 0.09 copies/actin after 12 hours of the U937
cells differentiation (Figure 5C). Decrease in the IL-6
gene expression level was observed to be 0.10 ± 0.01
copies/actin, 0.23 ± 0.02 copies/actin (p < 0.01), 0.37 ±
0.04 copies/actin (p < 0.001) and 0.45 ± 0.05 copies/actin
(p < 0.001) at 3, 6, 9 and 12 hours, respectively when the
U937 cells during differentiation were treated with
10 μg/ml MeOHGCM6 extract. Inhibition of the IL-6 gene
expression levels in the presence of the MeOHGCM6
extract was comparable to that of betamethasone.Prophylactic treatment effects of MeOHGCM6 extract on
the rats gastric contents following EtOH-induced acute
gastric mucosal injury
Gastric mucus secretion, gastric juice volume and gastric
mucus pH were determined from the gastric content of
rat’s stomach pre-treated with MeOHGCM6 extract
following EtOH feeding. 2.45 ± 0.25 gm of gastric mucus
and 1.75 ± 0.20 ml of gastric juice were recovered from
the stomach of rats fed with only the extract diluent
(Table 2). 1.54 ± 0.31 gm of gastric mucus and 0.96 ±
0.25 ml of gastric juice and 1.68 ± 0.19 gm of gastric
mucus and 0.96 ± 0.16 ml of gastric juice were recovered
from rats pre-treated with 250 and 500 mg/kg b.w. of
MeOHGCM6 extract, respectively. In comparison, 2.31 ±
0.42 gm of gastric mucus and 1.15 ± 0.36 ml gastric juice
was recovered from rats pre-treated with 20 mg/kg b.w
OMP. 2.75 ± 0.49 gm of gastric mucus and 1.75 ± 0.28 ml
of gastric juice were recovered from rats fed with similarly
prepared unrelated plant extract that served as the NSPE
control. This group of control produced high amount of
gastric mucus and gastric juice significantly compared to
rats treated with the MeOHGCM6 extract. The pH of
gastric mucus of rats pre-treated with 2.5, 5.0, 250 and
500 mg/kg b.w. MeOHGCM6 extract were 5.51 ± 0.86,
5.42 ± 0.71, 4.74 ± 0.38 and 3.82 ± 0.24, respectively
(Table 2). In comparison, the pH of mucus of rats treated
with the extract diluent, 20 mg/kg b.w. OMP and also
NPSE control were 7.40 ± 0.15, 6.97 ± 0.37 and 4.35 ± 0.19,
respectively.
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Figure 2 Expression of the differentiation-specific macrophage cell surface marker on differentiated U937 monocytic cells. U937
monocytic cells were induced to differentiate with (A) 0 nM PMA for 24 hours; (B) 0 nM PMA for 48 hours; (C) 1 nM PMA for 24 hours; (D) 1 nM
PMA for 48 hours; (E) 10 nM PMA for 24 hours; (F) 10 nM PMA for 48 hours; (G) 50 nM PMA for 24 hours and (H) 50 nM PMA for 48 hours. Cells
were stained using immunohistochemical staining to identify the presence of CD11b, a macrophage cell surface marker. Differentiated U937
monocytic cells were identified by the intense brownish blue stain on the cell surface of the differentiated cells. Cells were viewed at 20×
magnifications under brightfield using an inverted microscope and photographed using a Nikon D70 camera (Nikon, Japan). One archetypal set
of photographs from three separate experiments are shown.
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extract pre-treatment on production of gastric NP-SH
following EtOH-induced acute gastric mucosal injury
The level of NP-SH in the stomach was determined from
the glandular of rats pre-treated with MeOHGCM6
extract following EtOH-induced acute gastric mucosal
injury from the rat’s stomach. The level of NP-SH was at
0.15 ± 0.01 nmol/gm tissue in rats that were fed with the
diluent (Table 3). Comparable level (0.15 ± 0.01 nmol/gm
tissue) was obtained in stomach of rats pre-treated with
2.5 mg/kg b.w. MeOHGCM6 extract. The levels of NP-SH
in groups of rats pre-treated with 5.0, 250 and 500 mg/kg
b.w. MeOHGCM6 extract were 0.23 ± 0.01 nmol/g tissue,
0.33 ± 0.03 nmol/g tissue and 0.41 ± 0.02 nmol/gm tissue,
respectively and this showed a significant dose-dependentincrease. The level of NP-SH in the tissue of the group of
rats pre-treated with OMP was 0.33 ± 0.03 nmol/gm and
it was comparable to its counterpart in rats pre-treated
with 250 mg/kg b.w. MeOHGCM6 extract.
Effects of MeOHGCM6 extract treatment on gastric
lesions following EtOH-induced acute gastric mucosal
injury
The gastric histological lesions were observed from the
rat’s stomach pre-treated with MeOHGCM6 extract
following EtOH-induced acute gastric mucosal injury.
Macroscopic examination of the stomach of rats treated
with EtOH showed well-defined focal haemorrhagic
ulcerations or well-defined hemorrhagic erosions with
different sizes of red lines along the long axis of the
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Figure 3 Differentiation-specific U937 monocytic cells macrophage cell surface marker expression and cell viability determination.
U937 monocytic cells were induced to differentiate with various concentrations of PMA for 24 and 48 hours. (A) The percentages of differentiated
cells were scored by the presence of CD11b on the cell surface. (B) The percentages of viable cells were scored using trypan blue exclusion assay.
The percentage of differentiated or viable cells per total cells is the same prior to the experiment using the different concentrations of PMA and
incubation period. Data are presented as mean ± S.D. from three independent experiments with ‘*’, p < 0.05 represent significance difference in
comparison to the group that were not induced to differentiate.
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http://www.biomedcentral.com/1472-6882/13/61glandular portion of the stomach (Figure 6A). The
major EtOH-induced gastric lesions were approximately
about 1290.13 ± 88.16 mm2 in size and were observed in
rats pre-treated with the extract diluents (Table 4).
These findings were consistent with previous reported
findings [31]. Reduction in the ulcer area by 675 ±
304.02 mm2, 298.93 ± 56.06 mm2, 52.80 ± 20.25 mm2
and 7.20 ± 3.72 mm2 were observed in groups of rats
pre-treated with 2.5, 5.0, 250 and 500 mg/kg b.w.
MeOHGCM6 extract, respectively, compared to the
ulcer area within the stomach of the diluent-treated
control group (1290.13 ± 88.16 mm2) (Table 4). Almost
no lesion (>98%) was noted in rats pre-treated with
OMP prior to the treatment with EtOH (Figure 6C).MeOHGCM6 (µg/ml)
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Figure 4 Cytotoxicity effects of the various concentrations of MeOHG
proliferation rate of U937 monocytic cells treated with increasing concentr
determined over a period of 24 hours by performing MTT assay. The perce
prior to administrating the different doses of MeOHGCM6 extract and beta
30% (G130), 50% (G150) and 70% (G170) of cell proliferation inhibition were
expressed as the median (25% and 75% quartile) from two independent exThe rats pre-treated with 500 mg/kg b.w. MeOHGCM6
extract showed almost complete (>99%, p < 0.05) inhib-
ition of EtOH-induced ulceration comparable to or bet-
ter than the findings in rats treated with 20 gm/kg b.w.
OMP (Figure 6G, Table 4).
Discussion
Inflammation is a major feature of many diseases. It af-
fects 5% to 7% of the overall population worldwide [32].
Inflammation that occurs in the gastrointestinal tract is by
and large causes gastrointestinal ulcer. Gastrointestinal
ulcer disease poses a serious economic burden as treat-
ment for the ulcers account to at least 10% of the total
cost of treating digestive disorders [33,34]. EffectiveBetamethasone (nM)
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Figure 5 MeOHGCM6 extract treatment on TNF-α response level and TNF-α and IL-6 gene expression during differentiation of the
U937 monocytic cells. The U937 monocytic cells were induced to differentiate with 10 nM PMA. During differentiation, U937 monocytic cells
were treated with MeOHGCM6 extract. (A) The TNF-α response level were quantified using ELISA. The (B) TNF-α and (C) IL-6 gene expression
levels were quantified using qRT-PCR. Results were expressed as the mean ± S.D. from quadruplicate assays.
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http://www.biomedcentral.com/1472-6882/13/61treatment of this inflammation disorders using safer and
effective therapeutics remains an elusive goal. We inves-
tigated the standardised MeOHGCM6 extract of a
Malaysian red algae, Gracilaria changii (Xia et Abbott)
Abbott, Zhang et Xia, for its potential anti-inflammatory,
gastroprotective and anti-ulcerogenic activities.
In the present study, preparation of the extract was
standardized to ensure reproducibility of results and each
batch of extract was profiled using LC/MS. The profiling
of the MeOHGCM6 extract using LC/MS provided a de-
tailed chromatographic profile of the extract constituents.Table 2 The effects of MeOHGCM6 extract pre-treatment on t
gastric mucosal injury
Pretreatment (n = 6) Dose (mg/kg b.w.) Mucus produ
Diluent - 2.45 ± 0
NSPE 500.0 2.75 ± 1
OMP 20.0 2.31 ± 1
MeOHGCM6 2.5 2.33 ± 0
5.0 3.24 ± 1
250.0 1.54 ± 0
500.0 1.68 ± 0
Rats were fed with the diluent, NSPE, OMP and the different MeOHGCM6 extract co
sacrificed after an hour and gastric mucus secretion was collected and quantified. R
* Significance difference in comparison to the group pre-treated with 10% Tween 2Highly reproducible MeOHGCM6 extract mass spectral
peak profiles were used to mark the fraction identified
here as the standardized MeOHGCM6 extract for all the
subsequent experimentation. The preliminary profiling of
MeOHGCM6 extract revealed the presence of two
possible chlorophylls, methyl 10-hydroxyphaeophorbide a
and 10-hydroxypheophytin as the main constituents of
the MeOHGCM6 extract. Consistent with our finding,
pheophytin a, a type of chlorophyll-related compound
that has been found in green algae is proven to have
anti-inflammatory activities [35]. Whether these twohe rat’s gastric contents following EtOH-induced acute
ction (g) Volume of gastric juice (ml) Gastric pH
.61 1.75 ± 0.50 7.40 ± 0.37
.21 1.75 ± 0.69 4.35 ± 0.47*
.04 1.15 ± 0.88 6.97 ± 0.92
.77 1.50 ± 0.61 5.51 ± 2.10
.39 1.50 ± 0.61 5.42 ± 1.73
.77 0.96 ± 0.62 4.74 ± 0.93*
.47 0.96 ± 0.40 3.82 ± 0.58*
ncentrations 30 minutes prior to feeding with absolute EtOH. Rats were
esults are expressed as mean ± S.D. from six animals.
0 (untreated control) value: p < 0.05.
Table 3 The effects of MeOHGCM6 extract pre-treatment
on the production of gastric NP-SH in EtOH-induced
acute gastric mucosal injury
Pretreatment
(n = 6)
Dose
(mg/kg b.w.)
NP-SH concentration
(nmol/g tissue)
Diluent - 0.15 ± 0.04
NSPE 500.0 0.23 ± 0.03
OMP 20.0 0.33 ± 0.83*
MeOHGCM6 2.5 0.15 ± 0.57
5.0 0.23 ± 0.28
250.0 0.33 ± 0.69*
500.0 0.41 ± 0.53*
Rats were fed with the different concentrations of MeOHGCM6 extract
30 minutes prior to feeding with absolute EtOH. Rats were sacrificed an hour
later and the stomach was rapidly removed, the glandular stomach was
collected and the production of NP-SH was determined. Results are expressed
as mean ± S.D. from six animals.
* Significance difference in comparison to the group pre-treated with 10%
Tween 20 (untreated control) value: p < 0.05.
C
F
G
A
E
B
D
Figure 6 Effects of MeOHGCM6 extract treatment on the
gastric lesions following EtOH-induced acute gastric mucosal
injury. Rats were fed with the different concentrations of
MeOHGCM6 extract 30 minutes prior to feeding with 1 ml absolute
EtOH. Rats were sacrificed an hour later and the stomach was
rapidly removed and incised along the greater curvature. (A) Diluent.
(B) NSPE. (C) OMP. (D) 2.5 mg/kg b.w. MeOHGCM6. (E) 5 mg/kg b.w.
MeOHGCM6. (F) 250 mg/kg b.w. MeOHGCM6. (G) 500 mg/kg b.w.
MeOHGCM6. The untreated control stomachs showed extensive
EtOH-induced mucosal necrotic lesions mostly in the corpus
(arrows). Cells were photographed using a Nikon D70 camera. One
archetypal set of photographs are shown.
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http://www.biomedcentral.com/1472-6882/13/61chlorophylls, contributed to the anti-inflammatory
effects described herein is not known and will require
further investigation. However, a detailed profiling of
standardized MeOHGCM6 extract is required to cha-
racterize the compound that was responsible for the
mechanism involved.
Inflammatory model using monocyte differentiation
to macrophage-like cells was established in the study.
Characterization of macrophage-like cells to indicate
inflammatory effects is important, since these cells play
important role in inflammatory and immune responses
and also responsible for various immune functions such
as secretion of inflammatory mediators. U937 cell is a
suitable model since differentiation of this precursor cell
into macrophage-like cells can be studied conveniently
in response to various stimuli [36]. Differentiation was
determined by cell morphology and by physiological
markers. The number of differentiated cell increased
when U937 cells were induced to differentiate with
increasing concentration of PMA (1–50 nM) and longer
incubation period (24–48 hours). In our study, we used
viable, intact and metabolically active differentiated
U937 cells. During differentiation of the U937 cells, cells
were scored for the percentage of viable cells. A dose-
dependent reduction in cell viability of the differentiated
U937 cells was observed when the cells was induced to
differentiate with increasing concentration of PMA (1–
50 nM) and longer incubation period (24–48 hours).
Based on these results, U937 cells were induced to
differentiate with 10 nM PMA for 24 hours in all the
subsequent experiments. This study conditions were
chosen to ensure monocytic cells were more than 50%
differentiated to macrophage-like cells without affecting
cell viability and metabolic activity.The U937 cells during differentiation (macrophage-
mediated inflammatory phenomena) were then used to
investigate the anti-inflammatory activities of MeOHGCM6
extract. Results presented in this study suggest that
MeOHGCM6 extract can exert significant anti-
Table 4 The effects of MeOHGCM6 extract pre-treatment on the size of the EtOH-induced gastric lesions
Treatment (n = 6) Dose (mg/kg b.w.) UA (mm2) Inhibition (%)
Diluent - 1290.13 ± 215.95 -
NSPE 500.0 664.27 ± 143.01* 48.51
OMP 20.0 17.47 ± 14.20* 98.65
MeOHGCM6 2.5 675.00 ± 744.69* 47.68
5.0 298.93 ± 137.31* 76.83
250.0 52.80 ± 49.61* 95.91
500.0 7.20 ± 9.11* 99.44
Rats were fed with the different concentrations of MeOHGCM6 extract 30 minutes prior to feeding with absolute EtOH. Rats were sacrificed an hour later and the
stomach was rapidly removed and incised along the greater curvature and examined under a dissecting microscope. Results are expressed as mean ± S.D. from six
animals.
* Significance difference in comparison to the group pre-treated with 10% Tween 20 (untreated control) value: p < 0.05.
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http://www.biomedcentral.com/1472-6882/13/61inflammatory effects on TNF-α response level. Reduction
in the TNF-α response level was comparable to betame-
thasone, a commercially available anti-inflammatory drug
commonly used as treatment for inflammation [37].
Within 0–8 hours following differentiation of U937 cells,
we found a rapid increasing in TNF-α response level.
However, the TNF-α response of U937 cells during differ-
entiation was significantly blocked in the presence of the
10 μg/ml MeOHGCM6 extract. Our findings also suggest
that MeOHGCM6 extract can exert significant anti-
inflammatory effects on TNF-α and IL-6 gene expression
level. It was demonstrated by the ability of MeOHGCM6
extract to suppressed TNF-α and IL-6 gene expression
level during differentiation of the U937 cells. The suppres-
sive effects of MeOHGCM6 extract on pro-inflammatory
cytokines were unlikely to be due to non-specific cell
inhibition activity, since 10 μg/ml used for this studies
were non-cytotoxic to the cells. This finding is similar to
the previous studies which showed that red algae possess
the ability to inhibit in vitro inflammation and suppress
the production of inflammatory mediators [38,39].
Our results also suggest that the MeOHGCM6 extract
possesses gastroprotective and anti-ulcerogenic activities.
This was confirmed by the ability of MeOHGCM6 extract
treatment to ameliorate absolute EtOH-induced acute
gastric mucosal injury. Our findings showed that the
MeOHGCM6 extract when used to treat rats prior to
EtOH feeding accord protection of the gastrointestinal
tract against the EtOH-induced acute gastric mucosal
injury. The gastroprotective effect of MeOHGCM6 extract
was dose-dependent and the effect of treatment with
500 mg/kg b.w. was comparable to OMP, a widely pre-
scribed proton pump inhibitor that inhibits gastric acid
secretion used for the treatment of gastric ulcer [40]. The
non-specific beneficial effects of any plant extract is not
possible since we showed that rats pre-treated with an
unrelated but similarly prepared plant extract (NSPE), did
not present similar gastric responses and substantial
inhibition of the EtOH-induced acute gastric mucosal in-
jury. The mechanism contributing to the gastroprotectiveeffects of MeOHGCM6 extract, however is likely to be
different from that of OMP. The extract reduced gastric
juice and gastric mucus secretion and lowered the stom-
ach juice pH to 4.74 ± 0.38 at 250 mg/kg b.w. In contrast,
OMP reduced the gastric mucus secretion and neutralized
stomach juice pH to 6.97 ± 0.37. Our findings from OMP
treatment are similar to that previously reported [41].
Neutralization of stomach pH is among the known side
effects of OMP which could contribute to the alteration in
the stomach normal flora thus, predisposing to diarrheal
diseases. Decreasing the stomach juice pH by
MeOHGCM6 extract could be useful for restoration of
the normal flora [42] which might have contributed to the
gastroprotective and anti-ulcerogenic property of the
MeOHGCM6 extract. Our results also suggest that
MeOHGCM6 extract similar to OMP increases the gastric
NP-SH content. NP-SH has been shown to accord
gastroprotective effects against oxygen radicals inducing
agents such as EtOH [43,44]. The mechanisms of EtOH-
induced acute gastric mucosal injury are thought to arise
as a result of depletion of gastric mucus content, damaged
mucosal blood flow, haemorrhage and necrotic of mucosal
tissues and over production of free radicals which lead to
an increased lipid peroxidation [45]. The oxygen radicals
will then initiated the oxidative stress which contributes to
all forms of gastrointestinal ulcer. Consistent with our
finding, the red algae, Gracilaria changii has previously
been reported to possess free radical scavenging activity
[46]. A recent study has also shown that algae have anti-
oxidant properties which could be beneficial in the pre-
vention or treatment of gastric ulcers [22,47-49].
Conclusion
We demonstrated that the LC/MS standardised
MeOHGCM6 extract could modulate macrophage-
mediated pro-inflammatory cytokines over-production
in vitro. This property is consistent with its ability to
accord gastro protective effects against the EtOH-
induced acute gastric mucosal injury and ameliorate
the healing of the ulcers. The gastroprotective potentials
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http://www.biomedcentral.com/1472-6882/13/61of MeOHGCM6 extract may be in part due to its ability
to act as and reduced stomach acidity. An algae-based
medication with anti-inflammatory and gastric anti-
ulcerogenic activity is of great therapeutic importance
as most of the anti-inflammatory drugs used in modern
medicine are ulcerogenic. Further studies, however, are
required for elucidating the exact molecular and cellular
mechanisms of action and the effects of MeOHGCM6
extract in the treatment of chronic ulcers.
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